The manufacture of ZD2249 methoxy sulfoxide (1) using a newproject approach is described. Research department processeswere scaled up to 100 L if process safety and robustness werenot compromised; other factors were treated according to thenew approach. Using this strategy, we were able to manufacturea key intermediate on sufficient scale to support delivery of 1kg quantities of bulk drug within 6 months of the start of labwork.